Ameriprise
VXRT

Ameriprise’s Vaxart VXRT Stock Holding History

Ameriprise’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,016
Closed -$22K – 3936
2015
Q3 		$22K Buy
+1,016
New +$24.6K ﹤0.01% 3802

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ameriprise's VXRT Position: Q4 2015 in Review

Ameriprise sold out of Vaxart (VXRT) in Q4 2015, closing a stake of 1,016 shares — an estimated $22K sold.

Ameriprise first reported a position in VXRT in Q3 2015 and held it in 1 quarter. The position peaked at $22K in Q3 2015. 53 funds tracked by Wall St. Rank hold VXRT as of Q4 2015.

  • Ameriprise reported no remaining Vaxart position as of Q4 2015 after selling out during the quarter.
  • Ameriprise sold 1,016 Vaxart shares in Q4 2015, an estimated $22K.
  • Ameriprise first reported a position in Vaxart in Q3 2015 and held it in 1 quarter.
  • Ameriprise's Vaxart position peaked at $22K in Q3 2015.
  • 53 funds tracked by Wall St. Rank held Vaxart as of Q4 2015.

Based on Ameriprise's 13F filing for Q4 2015, filed 11 Feb 2016.